Care of the patient with Prader-Willi syndrome

Edilma L Yearwood1, Myrtle R McCulloch, Michelle L Tucker

  • 1Georgetown University School of Nursing and Health Studies, Washington, DC, USA.

Medsurg Nursing : Official Journal of the Academy of Medical-Surgical Nurses
|July 27, 2011
PubMed

Insights

Prader-Willi syndrome (PWS) is a rare genetic disorder causing obesity. This guide helps nurses manage PWS patients by detailing a multidisciplinary approach for their complex needs.

Area of Science:

  • Genetics
  • Neurodevelopmental Disorders
  • Endocrinology

Background:

  • Prader-Willi syndrome (PWS) is a complex genetic disorder affecting neurodevelopment.
  • It occurs across all races and genders with an incidence of 7 in 10,000-29,000.
  • PWS is the most common genetic cause of obesity.

Purpose of the Study:

  • To highlight a multidisciplinary approach for managing Prader-Willi syndrome in adults.
  • To outline essential elements for a comprehensive PWS treatment plan.
  • To support nurses in delivering effective biopsychosocial care for PWS patients.

Main Methods:

  • Literature review on Prader-Willi syndrome management.
  • Synthesis of multidisciplinary care principles.
  • Identification of key treatment plan components.

Main Results:

  • A comprehensive, multidisciplinary approach is crucial for PWS management.
  • Treatment plans must address the complex biopsychosocial needs of adults with PWS.
  • Nurses play a vital role in coordinating and delivering this care.

Conclusions:

  • Effective management of Prader-Willi syndrome requires a coordinated, multidisciplinary strategy.
  • Nurses are central to implementing comprehensive care plans for adults with PWS.
  • Addressing the unique biopsychosocial needs of PWS patients is paramount for improved outcomes.

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Personality Disorders: Paranoid and Schizoid01:22

Personality Disorders: Paranoid and Schizoid

Personality disorders represent enduring cognition, affect, and behavior patterns that significantly deviate from societal norms. These maladaptive traits often lead to difficulties in various domains, including interpersonal relationships, occupational settings, and overall psychological well-being. Paranoid personality disorder and schizoid personality disorder are two distinct conditions marked by odd or eccentric behavior.
Paranoid Personality Disorder
Paranoid personality disorder is...